About 5 300 reports

Chemical and Pharmaceutical Plants Construction in Kuwait to 2018: Market Databook

33 pages • By Timetric

SynopsisTimetric’s 'Chemical and Pharmaceutical Plants Construction in Kuwait to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance,...

400 500 320
Feb 2015

Poland Pharmaceuticals and Healthcare Report Q2 2015

110 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Polish pharmaceutical market is heavily dependent on public healthcare spending; any negative economic developments will have an impact on the market in the short term. Over the past five years, Poland's economic outperformance has been vital to maintaining positive...

985 1 300 818
Feb 2015

Japan Pharmaceuticals and Healthcare Report Q2 2015

156 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Japan's healthcare system will come under increasing financial strain due to the ageing population and the high use of patented medicines. This provides an impetus for the government to use cost containment measures including policies to encourage the uptake of generic...

985 1 300 818
Feb 2015

Peru Pharmaceuticals and Healthcare Report Q2 2015

114 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Longstanding trade agreements with the US and EU, along with efficient regulations for quality control will continue to make Peru an appealing destination for drugmakers. However, while the pharmaceutical and healthcare markets continue to grow, the national economy continues...

985 1 300 818
Feb 2015

Hong Kong Pharmaceuticals and Healthcare Report Q2 2015

118 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Hong Kong government will continue to shift healthcare provision towards the private sector due to the growing financial strain and an overburdened public healthcare system. While this could create cost barriers to medicines, we highlight that the strong earning power...

985 1 300 818
Feb 2015

Argentina Pharmaceuticals and Healthcare Report Q2 2015

138 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Despite economic activity forecast to continue to decline over the medium-term, Argentina's gradual transition towards more pragmatic and market-friendly economic policies will likely benefit key economic sectors in the long-term, including the pharmaceutical industry....

985 1 300 818
Feb 2015

Germany Pharmaceuticals and Healthcare Report Q2 2015

111 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: One of the largest markets in Europe, Germany will continue to experience rising demand for pharmaceuticals, sustained by an ageing population with a strong bias towards patented medicines. In spite of this, additional restrictions on reimbursement, tempered by government's...

985 1 300 818
Feb 2015

Mozambique Pharmaceuticals and Healthcare Report Q2 2015

54 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Mozambique's agricultural industry and natural resources contribute to its rapidly expanding economy, which will allow the Mozambican government to continue the development of healthcare infrastructure. The country's healthcare sector - which suffers from shortages of...

985 1 300 818
Feb 2015

Mauritius Pharmaceuticals and Healthcare Report Q1 2015

52 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: With high per-capita pharmaceutical expenditure and a stong governmental interest in pharmaceutical development, combined with a rising demand for non-communicable and chronic disease therapies, Mauritius plays host as an attractive destination for future growth - although...

985 1 300 818
Feb 2015

New Zealand Pharmaceuticals and Healthcare Report Q2 2015

85 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Despite policy initiatives designed to increase the pace of generic penetration, high latent demand for branded pharmaceuticals will continue to be underpinned by New Zealand's ageing and expanding population. However, the conversion of such potential into rewards for...

985 1 300 818
Feb 2015

Singapore Pharmaceuticals and Healthcare Report Q2 2015

132 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Singapore will remain a highly attractive manufacturing base for international pharmaceutical companies due to minimal levels of operational risks and the government's support for the industry. The pharmaceutical industry has been a key pillar of the country's economy...

985 1 300 818
Feb 2015

Tanzania Pharmaceuticals and Healthcare Report Q2 2015

81 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Tanzania's pharmaceutical market will continue to see growth with the continuing expansion of the country's National Health Insurance Fund. We highlight opportunities in the Tanzanian healthcare market which have come about thanks to the government's plans to introduce...

985 1 300 818
Feb 2015

Jordan Pharmaceuticals and Healthcare Report Q2 2015

119 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Jordan's government is attempting to achieve universal healthcare coverage, which we believe will become increasingly possible following the decision to no longer provide free medical treatment to Syrian refugees in Jordan. The government will have more funds to invest...

985 1 300 818
Feb 2015

Bulgaria Pharmaceuticals and Healthcare Report Q2 2015

104 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: In 2015, we expect the fallout from the banking and NHIF funding crises to impact pharmaceutical and healthcare spending, but given the passage of reforms to healthcare financing, we hold a more positive view for the long term development of the pharmaceutical & healthcare...

985 1 300 818
Feb 2015

Cystic Fibrosis Market in Europe 2015-2019

113 pages • By Infiniti Research Limited

About Cystic FibrosisCystic fibrosis, also known as mucoviscidosis, is a genetically inherited disease. The primary symptoms of cystic fibrosis include high salt content in the sweat, breathing difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic...

2 400 3 000 1 920
Feb 2015

The Generic Drugs Market: 2015 – 2030 - Opportunities, Challenges, Strategies & Forecasts

249 pages • By SNS Telecom

A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license from the innovator company and marketed after the expiry date of the patent or other exclusive rights.Already prevalent in the U.S., Europe and much of the developing world, generic drugs...

2 000 2 500 1 600
Feb 2015

Cameroon Pharmaceuticals and Healthcare Report Q2 2015

61 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Rapid population growth and economic development will drive Cameroon's pharmaceutical and healthcare market expansion over a multi-quarter timeframe, albeit from a low per capita spending level. The combination of rising consumer spending, global aid funds and Cameroon's...

985 1 300 818
Feb 2015

Gabon Pharmaceuticals and Healthcare Report Q2 2015

54 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Spending on pharmaceuticals in Gabon will be driven by the continued development of thecountry's National Health Insurance Scheme, and particularly by the expansion of the list of reimbursable drugs this quarter. Commercial opportunities exist in the Gabonese pharmaceutical...

985 1 300 818
Feb 2015

Czech Republic Pharmaceuticals and Healthcare Report Q2 2015

104 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: With recently implemented cost-saving measures, legislative changes, and health insurance reforms, the Czech Republic is set to recover from its recent period of stagnancy and decline. Indeed, these changes will help to provide for the growing demand for innovative drugs...

985 1 300 818
Feb 2015

Pakistan Pharmaceuticals and Healthcare Report Q2 2015

118 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Pakistan's epidemiological profile will undergo a transition as the burden of non-communicable diseases rises and communicable diseases decline. However, despite the clear need for medical care, poor medical infrastructure, low per capita pharmaceutical spending and high...

985 1 300 818
Feb 2015

Colombia Pharmaceuticals and Healthcare Report Q2 2015

123 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: President Juan Manuel Santos continues to push forward healthcare reform for medicine price controls and regulatory reformation. Though, such reforms still leave scepticism as Colombia's struggling economy and expanding counterfeit drug market continue to hinder progress...

985 1 300 818
Feb 2015

Israel Pharmaceuticals and Healthcare Report Q2 2015

134 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Israel offers an attractive pharmaceutical market, with the government committed to developing the public healthcare system. An improving intellectual property regime and high penetration of patented medicines will be seen as positive by innovative drugmakers. Risks to...

985 1 300 818
Feb 2015

Global Laboratory, Pharmaceutical and Hygienic Glassware Market to 2019 - Market Size, Growth, and Forecasts in Nearly 90 Countries

By MarketSizeInfo

This comprehensive publication enables readers the critical perspectives to be able to evaluate the world market for laboratory, pharmaceutical and hygienic glassware. The publication provides the market size, growth and forecasts at the global level as well as for the following countries:Albania, Argentina, Armenia, Australia, Austria,...

1 990 2 488 1 592
Feb 2015

Active Pharmaceutical Ingredients (API) Market in the US 2015-2019

65 pages • By Infiniti Research Limited

About APIActive pharmaceutical ingredients (API) are active substances that are used in the manufacture of drugs and that have pharmacological effects. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are...

2 000 2 500 1 600
Feb 2015

Global Migraine Drugs Market 2015-2019

110 pages • By Infiniti Research Limited

About MigraineMigraine is a complex neurological medicial condition characterized by a severe headache. The headache is often accompanied by nausea, vomiting, and extreme sensitivity to light and sound. Given their hormonal fluctuation, women are more susceptible to have migraine than men. Anti-migraine drugs are the therapeutic agents...

2 400 3 000 1 920
Feb 2015

Nigeria Pharmaceuticals and Healthcare Report Q2 2015

118 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Nigeria's pharmaceutical and healthcare markets are vastly underdeveloped by Western standards as poor infrastructure, a weak regulatory system and lack of specialised facilities weaken growth potential. However, the Nigerian government's continuing efforts to expand...

985 1 300 818
Feb 2015

Croatia Pharmaceuticals and Healthcare Report Q2 2015

94 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: We expect the newfound independence of the national health insurer (HZZO) to have negative consequences for the pharmaceutical sector, as it will use its purchasing power to extract price cuts from drugmakers. With Croatia's economy set to stagnate, containing costs will...

985 1 300 818
Feb 2015

Netherlands Pharmaceuticals and Healthcare Report Q2 2015

112 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Although the Dutch economy is expected to grow above the eurozone average over 2015 and 2016, the government will most likely continue to target the healthcare sector, resulting in further drug price cuts as it responds to rising healthcare costs from the demands of an...

985 1 300 818
Feb 2015

Algeria Pharmaceuticals and Healthcare Report Q2 2015

99 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Algerian government's five-year investment and industrial development plan to be implemented from 2015-2019 will provide opportunities to foreign drugmakers looking to enter the Algerian pharmaceutical market or to expand their operations in the region through strategic...

985 1 300 818
Feb 2015

Mexico Pharmaceuticals and Healthcare Report Q2 2015

132 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Increased trade activity will promote growth in Mexico's pharmaceutical and healthcare markets in 2015. In particular, generic medicine will continue to grow over the forecast period, accounting for a larger percentage of total pharmaceutical spending. Indeed, the country...

985 1 300 818
Feb 2015